How does Elanco Animal Health Inc (ELAN) change from a tortoise to a hare?

With 6.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.81 million shares. The 52-week range on ELAN shows that it touched its highest point at $18.80 and its lowest point at $10.20 during that stretch. It currently has a 1-year price target of $16.50. Beta for the stock currently stands at 1.45.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ELAN was down-trending over the past week, with a drop of -0.98%, but this was down by -7.79% over a month. Three-month performance dropped to -16.94% while six-month performance fell -23.61%. The stock lost -32.01% in the past year, while it has lost -8.09% so far this year. A look at the trailing 12-month EPS for ELAN yields 0.68 with Next year EPS estimates of 0.99. For the next quarter, that number is 0.31. This implies an EPS growth rate of -5.92% for this year and 16.10% for next year. EPS is expected to grow by 8.04% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 29.95%.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ELAN since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.93338 being high and $0.90327 being low. For ELAN, this leads to a yearly average estimate of $0.91331. Based on analyst estimates, the high estimate for the next quarter is $0.3 and the low estimate is $0.21. The average estimate for the next quarter is thus $0.25.